Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mackensen

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Cell Reports|April 2, 2014
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activityAnja Lux, Michaela Seeling, Anne Baerenwaldt, et al.
Oncotarget|April 9, 2019
Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccinesJulia M Kittler, Jonas Sommer, Anika Fischer, et al.
Journal of Clinical Medicine|August 12, 2022
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA TrialKatja Schlichtig, Lisa Cuba, Pauline Dürr, et al.
Mabs|February 14, 2012
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
British Journal of Haematology|July 20, 2010
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targetingMarkus Kügler, Christoph Stein, Christian Kellner, et al.
Mabs|November 18, 2010
A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
Oncoimmunology|June 15, 2018
D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarizationMartin Böttcher, Kathrin Renner, Raffaela Berger, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognitionTamson V Moore, Gretchen E Lyons, Natasha Brasic, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
Transplantation and Cellular Therapy|March 28, 2024
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine ProductionJanin Dingfelder, Michael Aigner, Jule Taubmann, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Cell Reports|April 2, 2014
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activityAnja Lux, Michaela Seeling, Anne Baerenwaldt, et al.
Oncotarget|April 9, 2019
Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccinesJulia M Kittler, Jonas Sommer, Anika Fischer, et al.
Journal of Clinical Medicine|August 12, 2022
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA TrialKatja Schlichtig, Lisa Cuba, Pauline Dürr, et al.
Mabs|February 14, 2012
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
British Journal of Haematology|July 20, 2010
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targetingMarkus Kügler, Christoph Stein, Christian Kellner, et al.
Mabs|November 18, 2010
A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
Oncoimmunology|June 15, 2018
D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarizationMartin Böttcher, Kathrin Renner, Raffaela Berger, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognitionTamson V Moore, Gretchen E Lyons, Natasha Brasic, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
Transplantation and Cellular Therapy|March 28, 2024
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine ProductionJanin Dingfelder, Michael Aigner, Jule Taubmann, et al.
Pageof 20